Browse > Article

False Positive and False Negative FDG- PET Scans in Various Thoracic Diseases  

Chang, Jung-Min (Department of Radiology, Seoul National University Hospital)
Lee, Hyun-Ju (Department of Radiology, Seoul National University Hospital)
Goo, Jin-Mo (Department of Radiology, Seoul National University Hospital)
Lee, Ho-Young (Department of Nuclear Medicine, Seoul National University Hospital)
Lee, Jong-Jin (Department of Nuclear Medicine, Seoul National University Hospital)
Chung, June-Key (Department of Nuclear Medicine, Seoul National University Hospital)
Im, Jung-Gi (Department of Radiology, Seoul National University Hospital)
Publication Information
Korean Journal of Radiology / v.7, no.1, 2006 , pp. 57-69 More about this Journal
Abstract
Fluorodeoxyglucose (FDG)-positron emission tomography (PET) is being used more and more to differentiate benign from malignant focal lesions and it has been shown to be more efficacious than conventional chest computed tomography (CT). However, FOG is not a cancer-specific agent, and false positive findings in benign diseases have been reported. Infectious diseases (mycobacterial, fungal, bacterial infection), sarcoidosis, radiation pneumonitis and post-operative surgical conditions have shown intense uptake on PET scan. On the other hand, tumors with low glycolytic activity such as adenomas, bronchioloalveolar carcinomas, carcinoid tumors, low grade lymphomas and small sized tumors have revealed false negative findings on PET scan. Furthermore, in diseases located near the physiologic uptake sites (heart, bladder, kidney, and liver), FDG-PET should be complemented with other imaging modalities to confirm results and to minimize false negative findings. Familiarity with these false positive and negative findings will help radiologists interpret PET scans more accurately and also will help to determine the significance of the findings. In this review, we illustrate false positive and negative findings of PET scan in a variety of diseases.
Keywords
Computed tomography (CT); Positron emmosion tomography(PET); Thoracic diseases;
Citations & Related Records

Times Cited By Web Of Science : 55  (Related Records In Web of Science)
Times Cited By SCOPUS : 65
연도 인용수 순위
1 Goo JM, Im JG, Do KH, Yeo JS, Seo JB, Kim HY, et al. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology 2000;216:117-121   DOI
2 Kostakoglu L, Agress H, Goldsmith SJ. Clinical role of FDG PET in evalutaion of cancer patients. RadioGraphics 2003;23:315-340   DOI   ScienceOn
3 Bennett JE. Cryptococcosis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principle of internal medicine 15th ed. NewYork: McGraw-Hill, 2001;1174-1175
4 Lorenzen J, Buchert R, Bleckmann C, Munchow N, Bohuslavizki KH. A search for the focus in patients with fever of unknown origin: is positron-emission tomography with F-18- fluorodeoxyglucose helpful? Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1999;171:49-53   DOI   ScienceOn
5 Lin P, Chu J, Pocock N. Fluorine -18 FDG dual-head gamma camera coincidence imaging of radiation pneumonitis. Clin Nucl Med 2000;25:866-869   DOI   ScienceOn
6 Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-1980
7 Avril N, Rose CA, Schelling M, Dose J, Kuhn W, Bense S, et al. Breast imaging with positron emission tomography and fluorine- 18 fluorodeoxtglucose: use and limitations. J Clin Oncol 2000;18:3495-3502   DOI
8 Watanabe S, Nakamura Y, Kariatsumari K, Nagata T, Sakata R, Zinnouchi S, et al. Pulmonary paragonimiasis mimicking lung cancer on FDG-PET imaging. Anticancer Res 2003;23:3437- 3440
9 Im JG, Kong Y, Shin YM, Yang SO, Song JG, Han MC, et al. Pulmonary paragonimiasis: clinical and experimental studies. RadioGraphics 1993;13:575-586   DOI
10 Erasmus JJ, McAdams HP, Patz EF Jr, Coleman RE, Ahuja V, Goodman PC. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol 2004;182:559- 567   DOI   ScienceOn
11 Kim B, Kim Y, Lee K, Yoon SB, Cheon EM, Kwon OJ, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 1998;170:935-939   DOI   ScienceOn
12 Berger KL, Nicholson SA, Dehdashti F, Siegel BA. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol 2000;174: 1005-1008   DOI   ScienceOn
13 Speizer FE. Environmental lung diseases. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Principle of internal medicine, 15th ed. NewYork: McGraw-Hill, 2001;1470-1471
14 Trukington TG, Coleman RE. Clinical oncologic PET: An Introduction. Semin Roentgenol 2002;37:102-109   DOI   ScienceOn
15 Amerein PC, Larson SM, Wagner HN Jr. An automated system for measurement of leukocyte metabolism. J Nucl Med 1975;15:352-355
16 Hara M, Iida A, Tohyama J, Miura N, Shiraki N, Itoh M, et al. FDG-PET findings in sclerosing hemangioma of the lung: a case report. Radiat Med 2001;19:215-218
17 Gupta NC, Graeber GM, Bishop HA. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (< 1 cm), intermediate (1 to 3 cm), and large (> 3 cm) lymph node lesions. Chest 2000;117: 773-778   DOI   ScienceOn
18 Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, Bhargava P, et al. Positron emission tomography Imaging in nonmalignant thoracic disorders. Semin Nucl Med 2002;32: 293-321   DOI   ScienceOn
19 Ryu JS, Choi NC, Fischman AJ, Lynch TJ, Mathisen DJ. FDGPET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. Lung Cancer 2002;35:179-187   DOI   ScienceOn
20 Brudin LH, Valind SO, Rhodes CG, Pantin CF, Sweatman M, Jones T, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994;21:297-305   DOI
21 Montravers F, Grahek D, Kerrou K, Younsi N, Doublet JD, Gattegno B, et al. Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera. J Nucl Med 2000;41:78-84
22 Crystal RG. Disorders of the immune system, connective tissue, and joints, sarcoidosis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principle of internal medicine, 15th ed. NewYork: McGraw-Hill, 2001;1969- 1970
23 Bakheet SM, Powe J. Benign causes of 18-FDG uptake on whole body imaging. Semin Nucl Med 1998;28:352-358   DOI   ScienceOn